Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


GREY:CLAZF - Post by User

Comment by Amazighon Sep 09, 2021 1:19pm
107 Views
Post# 33834170

RE:Fellow Investors !!!

RE:Fellow Investors !!!
HighSkies2019 wrote: as for GVHD many thought it had great potential and I still do ..until I see it confirmed from the company


Do you have $14 million HighSkies? Because to bring it back you need $4 million to pay Talent off in lieu of the program and another $7 million to run phase III plus another $3 million to keep the company going through that phase III.

HighSkies2019 wrote: the end result .. I have never saw a post that they stated FDA approved....but we all had the same expectations hopes for FDA accelerated ..when covid hit R107 we were fortunate to have a connection and it became our front runner ...now let's see what the company has done for us ... I slur towards my fellow long peers from time to time ...its only because they come as a group from other certain boards... they come off smug with posts towards their fellow long peers mocking them because their peers were expressing their thoughts or concerns in a post ...


Yes, facts are like sunlight to cockroaches.

HighSkies2019 wrote: ...on their boards they kick investors out that don't agree with them...


Wrong. They boot people off who do not obey the rules. It is stated right in the rules that counterarguments within the boundaries of those rules are more than welcome.

You are still a member as is everybody else who has not broken the rules – none of which demand that the Admin be agreed with. In fact, many of them disagree with the Admin there but they do it within the rules.


If you like you can see the documentation of who and why they were banned by going here:

https://claritasinvestors.com/index.php?/topic/939-corrective-actions/
<< Previous
Bullboard Posts
Next >>